GL1X · GenesisL1 explorer

MolNFT v1 · #68988 · protein

A novel chemotype of kinase inhibitors

3KCK · Tyrosine-protein kinase JAK2: “A novel chemotype of kinase inhibitors”. X-ray diffraction, 1 ligand (3KC), 1 pocket (best druggability 0.72). MolNFT v1 #68988 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3KCK
Type
protein
Length
287 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
3KC
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28746% helix, 19% strandO60674

Ligands and binding sites

  • 3KC · 3-chloro-4-(4H-3,4,7-triazadibenzo[cd,f]azulen-6-yl)phenol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16250.720.79613KC

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 3KCK · A Novel Chemotype of Kinase Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.